𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment for plexiform neurofibromas in patients with NF1

✍ Scribed by Simone L Ardern-Holmes; Kathryn N North


Book ID
119609062
Publisher
The Lancet
Year
2012
Tongue
English
Weight
139 KB
Volume
13
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Plexiform neurofibromas in NF1
✍ Thomas R. Welch πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 94 KB
NF1 mutations in neurofibromatosis 1 pat
✍ Lan Kluwe; Reinhard E. Friedrich; Bruce Korf; Raimund Fahsold; Victor-F. Mautner πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 1 views

Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2. About 30% of NF1 patients develop plexiform neurofibromas (PNFs), which often cause severe clinical deficits. To determine whether there is a certain genotype underlying PNFs or subt

Germline and somatic NF1 gene mutations
✍ Meena Upadhyaya; Gill Spurlock; Bisma Monem; Nick Thomas; Reinhard E. Friedrich; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

Neurofibromatosis type 1 (NF1), a common autosomal dominant neurogenetic disorder affecting 1 in 4000 individuals worldwide, results from functional inactivation of the 17q11.2-located NF1 gene. Plexiform neurofibroma (PNF) is a congenital benign tumour present in 30-50% of NF1 patients, which in ab